Urovant Sciences Ltd. Business Operations Contracts & Agreements
15 Contracts & Agreements
- Collaboration Agreements (3 contracts)
- Cooperation Agreements (2)
- Indemnification Agreements (2)
- Services Agreements (5)
- Supply Agreements (2)
- Voting Agreements (1)
- Second Amendment to Market Access Services Agreement, dated January 8, 2021, by and between the Company and Sunovion Pharmaceuticals, Inc (Filed With SEC on February 12, 2021)
- First Amendment to Market Access Services Agreement, dated December 21, 2020, by and between the Company and Sunovion Pharmaceuticals, Inc (Filed With SEC on February 12, 2021)
- Voting and Support Agreement, dated as of November 12, 2020, between Urovant Sciences Ltd. and Sumitovant Biopharma Ltd (Filed With SEC on November 13, 2020)
- Market Access Services Agreement, dated June 17, 2020, by and between the Company and Sunovion Pharmaceuticals Inc (Filed With SEC on August 13, 2020)
- Information Sharing and Cooperation Agreement, dated May 21, 2020, by and between Urovant Sciences, Ltd. and Sumitovant Biopharma Ltd (Filed With SEC on May 28, 2020)
- Form of Indemnification Agreement with officers and directors (Filed With SEC on April 6, 2020)
- Enzyme Supply Agreement, effective as of September 1, 2017, by and between Urovant Sciences GmbH and Codexis, Inc (Filed With SEC on September 10, 2018)
- Collaboration Agreement, dated as of August 24, 2017, by and between Urovant Sciences GmbH and Kyorin Pharmaceutical Co., Ltd (Filed With SEC on September 10, 2018)
- Form of Indemnification Agreement with directors and executive officers (Filed With SEC on August 30, 2018)
- Information Sharing and Cooperation Agreement, dated as of July 9, 2018, by and between Roivant Sciences Ltd. and the Registrant (Filed With SEC on July 13, 2018)
- Amended and Restated Services Agreement, effective as of July 9, 2018, by and among Roivant Sciences GmbH and Urovant Sciences GmbH (Filed With SEC on July 13, 2018)
- Amended and Restated Services Agreement, effective as of July 9, 2018, by and among Roivant Sciences, Inc., Urovant Sciences GmbH, Urovant Sciences, Inc. and the Registrant (Filed With SEC on July 13, 2018)
- Enzyme Supply Agreement, effective as of September 1, 2017, by and between Urovant Sciences GmbH and Codexis, Inc (Filed With SEC on July 13, 2018)
- Collaboration Agreement, dated June 1, 2018, by and between Urovant Sciences GmbH and Roivant Sciences GmbH (Filed With SEC on July 13, 2018)
- Collaboration Agreement, dated as of August 24, 2017, by and between Urovant Sciences GmbH and Kyorin Pharmaceutical Co., Ltd (Filed With SEC on July 13, 2018)
